Melanocortin receptor agonists

Details for Australian Patent Application No. 2001264977 (hide)

Owner Merck & Co., Inc.

Inventors Ye, Zhixiong; Nargund, Ravi P.; Bakshi, Raman Kumar

Agent Spruson & Ferguson

Pub. Number AU-B-2001264977

PCT Pub. Number WO01/91752

Priority 60207918 30.05.00 US

Filing date 25 May 2001

Wipo publication date 11 December 2001

Acceptance publication date 14 April 2005

International Classifications

A61K 031/437

C07D 233/88 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 471/02 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/4164 - 1,3-Diazoles

A61K 031/47 - Quinolines

Event Publications

14 April 2005 Application Accepted

  Published as AU-B-2001264977

11 August 2005 Standard Patent Sealed

17 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001264978

2001264976-Apparatus and method for obtaining blood for diagnostic tests